Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07863318
ABSTRACT:
The present invention relates to cyclopentane heptenoic acid-5-cis-2-(3α-hydroxy or lower alkyloxy-5-thienylpentyl)-3, 5-dihydroxy, [1α, 2β, 3α, 5α] compounds, lower alkyl, hydroxyl lower alkyl and indole lower alkyl amides and esters thereof as potent ocular hypotensives that are particularly suited for the management of glaucoma.
REFERENCES:
patent: 5352708 (1994-10-01), Woodward et al.
patent: 5741810 (1998-04-01), Burk
patent: 5834498 (1998-11-01), Burk
patent: 6124344 (2000-09-01), Burk
patent: 6160129 (2000-12-01), Burk
patent: 6476064 (2002-11-01), Old et al.
patent: 6734206 (2004-05-01), Old et al.
patent: 6747037 (2004-06-01), Old et al.
Allergan Inc.
Ene Doina G.
Forrestal Kevin J.
Hartley Michael G
Samala Jagadishwar R
LandOfFree
Prostaglandins and analogues as agents for lowering... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandins and analogues as agents for lowering..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandins and analogues as agents for lowering... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2673355